The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Abstract
Cancer treatment by conventional chemotherapy is hindered by toxic side effects and the frequent development of multi-drug resistance by cancer cells. Cationic antimicrobial peptides (CAPs) are a promising new class of natural-source drugs that may avoid the shortcomings of conventional chemotherapy because certain CAPs exhibit selective cytotoxicity against a broad spectrum of human cancer cells, including neoplastic cells that have acquired a multi-drug-resistant phenotype. Tumour cell killing by CAPs is usually by a cell membrane-lytic effect, although some CAPs can trigger apoptosis in cancer cells via mitochondrial membrane disruption. Furthermore, certain CAPs are potent inhibitors of blood vessel development (angiogenesis) that is associated with tumour progression. This article reviews the mechanisms by which CAPs exert anticancer activity and discusses the potential application of selected CAPs as therapeutic agents for the treatment of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643 · cited 1×
“Furthermore, cancer cells frequently develop resistance to many anticancer drugs, which greatly reduces their therapeutic usefulness [5,6].”
BackgroundProgress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Gray, M. W., Burger, G., & Lang, B. F. (1999) · Science · doi:10.1126/science.283.5407.1476 · Cited by 1,719
Sequence and specificity of two antibacterial proteins involved in insect immunity
Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981) · Nature · doi:10.1038/292246a0 · Cited by 1,427
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Action of Antimicrobial Peptides: Two-State Model
Huang, H. W. (2000) · Biochemistry · doi:10.1021/bi000946l · Cited by 740
LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES
Masson, P. L., Heremans, J. F., & Schonne, E. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.3.643 · Cited by 700
Mammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
A Bactericidal Effect for Human Lactoferrin
Arnold, R. R., Cole, M. F., & McGhee, J. R. (1977) · Science · doi:10.1126/science.327545 · Cited by 676
Defensins of vertebrate animals
Lehrer, R. I., & Ganz, T. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00303-x · Cited by 662
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K., & Tomita, M. (1992) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1992.tb05007.x · Cited by 588
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
hBD‐1: a novel β‐defensin from human plasma
Bensch, K. W., Raida, M., Mägert, H.-J., Schulz-Knappe, P., & Forssmann, W.-G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00687-5 · Cited by 545
Primary structures of three human neutrophil defensins.
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112121 · Cited by 534
Kagan, B. L., Selsted, M. E., Ganz, T., & Lehrer, R. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.210 · Cited by 532
Nakamura, T., Furunaka, H., Miyata, T., Tokunaga, F., Muta, T., Iwanaga, S., Niwa, M., Takao, T., & Shimonishi, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37448-9 · Cited by 531
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Bechinger, B. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00205-9 · Cited by 498
Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran, S., Downes, A., & Thorpe, P. E. (2002) · PubMed · Cited by 471
Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin
Tomita, M., Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., & Kawase, K. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78608-6 · Cited by 445
Lactoferrin in milk from different species
Masson, P. L., & Heremans, J. F. (1971) · Comparative Biochemistry and Physiology Part B: Comparative Biochemistry · doi:10.1016/0305-0491(71)90258-6 · Cited by 444
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin.
Lee, J. Y., Boman, A., Sun, C. X., Andersson, M., Jörnvall, H., Mutt, V, & Boman, H. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9159 · Cited by 435
PR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386
Antimicrobial activity of synthetic magainin peptides and several analogues.
Zasloff, M., Martin, B., & Chen, H. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.910 · Cited by 373
Role of mitochondria as the gardens of cell death
Kim, R., Emi, M., & Tanabe, K. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0111-7 · Cited by 326
Defensins and other endogenous peptide antibiotics of vertebrates
Martin, E., Ganz, T., & Lehrer, R. I. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.2.128 · Cited by 309
Naumov, G. N., Townson, J. L., MacDonald, I. C., Wilson, S. M., Bramwell, V. H. C., Groom, A. C., & Chambers, A. F. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004377.12288.3c · Cited by 305
Oxaliplatin-related side effects: Characteristics and management
Cassidy, J., & Misset, J.-L. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)90016-3 · Cited by 298
Changes in electric charge and phospholipids composition in human colorectal cancer cells
Dobrzyńska, I., Szachowicz-Petelska, B., Sulkowski, S., & Figaszewski, Z. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3557-3 · Cited by 285
Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines
Mader, J. S., Salsman, J., Conrad, D. M., & Hoskin, D. W. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0077 · Cited by 264
Self-citationIn vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes
Lichtenstein, A., Ganz, T., Selsted, M., & Lehrer, R. (1986) · Blood · doi:10.1182/blood.v68.6.1407.1407 · Cited by 263
Hwang, P. M., Zhou, N., Shan, X., Arrowsmith, C. H., & Vogel, H. J. (1998) · Biochemistry · doi:10.1021/bi972323m · Cited by 252
Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A., & Zanetti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28375 · Cited by 252
de Kroon, A. I. P. M., Dolis, D., Mayer, A., Lill, R., & de Kruijff, B. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(96)00240-4 · Cited by 239
Anticancer efficacy of Magainin2 and analogue peptides.
Baker, M. A., Maloy, W. L., Zasloff, M., & Jacob, L. S. (1993) · PubMed · Cited by 236
Sandgren, S., Wittrup, A., Cheng, F., Jönsson, M., Eklund, E., Busch, S., & Belting, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311440200 · Cited by 236
Innate mechanisms of epithelial host defense: spotlight on intestine
Hecht, G. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c351 · Cited by 230
Wilde, C. G., Griffith, J. E., Marra, M. N., Snable, J. L., & Scott, R. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60449-1 · Cited by 224
The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215 · cited 1×
“Although mastoparan kills both transformed and untransformed cells by the potent induction of mitochondrial permeability transition [108], targeted delivery of mastoparan or other CAPs that are toxic to healthy cells via transferrin-modified fusogenic liposomes is expected to minimise nonspecific toxicity by specifica…”
BackgroundOligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines
Burdick, M. D., Harris, A., Reid, C. J., Iwamura, T., & Hollingsworth, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24198 · Cited by 215
Angiogenic inhibitors: a new therapeutic strategy in oncology
Gasparini, G., Longo, R., Toi, M., & Ferrara, N. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0342 · Cited by 212
Takeshima, K., Chikushi, A., Lee, K.-K., Yonehara, S., & Matsuzaki, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208762200 · Cited by 210
An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma
Sørensen, O., Cowland, J. B., Askaa, J., & Borregaard, N. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00084-7 · Cited by 209
The Peptide Mastoparan Is a Potent Facilitator of the Mitochondrial Permeability Transition
Pfeiffer, D. R., Gudz, T. I., Novgorodov, S. A., & Erdahl, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4923 · Cited by 208
Yoo, Y., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., & Azuma, I. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00364.x · Cited by 197
Function and therapeutic potential of host defence peptides
Mcphee, J. B., & Hancock, R. E. W. (2005) · Journal of Peptide Science · doi:10.1002/psc.704 · Cited by 182
Eliassen, L. T., Berge, G., Leknessund, A., Wikman, M., Lindin, I., Løkke, C., Ponthan, F., Johnsen, J. I., Sveinbjørnsson, B., Kogner, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21886 · Cited by 181
Overview of Tumor Cell Chemoresistance Mechanisms
Gatti, L., & Zunino, F. (2005) · Chemosensitivity · doi:10.1385/1-59259-889-7:127 · Cited by 179
Papo, N., & Shai, Y. (2003) · Biochemistry · doi:10.1021/bi027212o · Cited by 174
Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity
Risso, A. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.6.785 · Cited by 170
Evidence for a direct antitumor mechanism of action of bovine lactoferricin.
Eliassen, L. T., Berge, G., Sveinbjørnsson, B., et al. (2003) · PubMed · Cited by 165
Papo, N., Shahar, M., Eisenbach, L., & Shai, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211204200 · Cited by 165
Preliminary experimental anticancer activity of cecropins.
Moore, A., Devine, D., & Bibby, M. C. (1994) · PubMed · Cited by 165
Membrane fluidity characteristics of human lung cancer
Sok, M., Šentjurc, M., & Schara, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00044-0 · Cited by 163
Antitumor activity of magainin analogues against human lung cancer cell lines.
Ohsaki, Y., Gazdar, A. F., Chen, H. C., & Johnson, B. (1992) · PubMed · Cited by 157
Risso, A., Braidot, E., Sordano, M. C., Vianello, A., Macrì, F., Skerlavaj, B., Zanetti, M., Gennaro, R., & Bernardi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1926-1935.2002 · Cited by 156
Chen, H. M., Wang, W., Smith, D. K., & Chan, S. C. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00024-x · Cited by 154
Vorland, L. H. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850161557 · Cited by 154
Cooperative membrane insertion of magainin correlated with its cytolytic activity
Ludtke, S. J., He, K., Wu, Y., & Huang, H. W. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90050-7 · Cited by 153
Potential Therapeutic Applications of Magainins and other Antimicrobial Agents of Animal Origin
Jacob, L. S., & ZASLOFF, M. A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514658.ch12 · Cited by 150
Yoo, Y., Watanabe, R., Koike, Y., Mitobe, M., Shimazaki, K., Watanabe, S., & Azuma, I. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7199 · Cited by 148
Okumura, K., Itoh, A., Isogai, E., Hirose, K., Hosokawa, Y., Abiko, Y., Shibata, T., Hirata, M., & Isogai, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.006 · Cited by 147
Cytotoxicity and Apoptosis Mediated by Two Peptides of Innate Immunity
Risso, A., Zanetti, M., & Gennaro, R. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1358 · Cited by 146
Chavakis, T., Cines, D. B., Rhee, J.-S., Liang, O. D., Schubert, U., Hammes, H., Higazi, A. A., Nawroth, P. P., Preissner, K. T., & Bdeir, K. (2004) · The FASEB Journal · doi:10.1096/fj.03-1009fje · Cited by 145
Woodle, M. C. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90069-f · Cited by 142
Haukland, H. H., Ulvatne, H., Sandvik, K., & Vorland, L. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03100-3 · Cited by 128
PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130Cas
Chan, Y. R., & Gallo, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28978 · Cited by 116
Swenson, S. D., Costa, F. K., Minea, R. O., Sherwìn, R. P., Ernst, W. A., Fujii, G., Yang, D., & Markland, F. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.499.3.4 · Cited by 112
Effect of O-Glycosylated Mucin on Invasion and Metastasis of HM7 Human Colon Cancer Cells
Yoon, W.-H., Park, H.-D., Lim, K., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0806 · Cited by 110
Yamada, Y., Shinohara, Y., Kakudo, T., Chaki, S., Futaki, S., Kamiya, H., & Harashima, H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.009 · Cited by 97
Conformation and Antimicrobial Activity of Linear Derivatives of Tachyplesin Lacking Disulfide Bonds
Rao, A. G. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0962 · Cited by 91
Chemotherapy for multiple myeloma
Alexanian, R., & Dreicer, R. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3<411::aid-cncr2820530308>3.0.co;2-e · Cited by 90
Russell, P. J., Hewish, D. R., Carter, T. E., Sterling-Levis, K., Ow, K. T., Hattarki, M. K., Doughty, L., Guthrie, R. E., Shapira, D. R., Molloy, P. L., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0457-9 · Cited by 87
Holle, L., Song, W., Holle, E., Wei, Y., Wagner, T. E., & Yu, X. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.1.93 · Cited by 81
The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.
Hui, L., Leung, K., & Chen, H. M. (2002) · PubMed · Cited by 77
Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T., & Kaku, T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.07.001 · Cited by 75
Roy, M. K., Kuwabara, Y., Hara, K., Watanabe, Y., & Tamai, Y. (2002) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(02)74284-7 · Cited by 74
Liposome reconstitution of a minimal protein‐mediated membrane fusion machine
Top, D., de Antueno, R., Salsman, J., Corcoran, J. A., Mader, J. S., Hoskin, D. W., Touhami, A., Jericho, M. H., & Duncan, R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600767 · Cited by 64
Self-citationOhtake, T., Fujimoto, Y., Ikuta, K., Saito, H., Ohhira, M., Ōno, M., & Kohgo, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690707 · Cited by 57
Biosynthesis of Melittin, a Toxic Peptide from Bee Venom
Kreil, G. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb02716.x · Cited by 49
Effects of a Lytic Peptide Conjugated to β hCG on Ovarian Cancer: Studies in Vitro and in Vivo
Gawrońska‐Kozak, B., Leuschner, C., Enright, F. M., & Hansel, W. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6558 · Cited by 48
Tanaka, K., Fujimoto, Y., Suzuki, M., Suzuki, Y., Ohtake, T., Saito, H., & Kohgo, Y. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01187.x · Cited by 45
Scanning electron microscopic analysis of breast aspirates
CHAUDHARY, J., & Munshi, M. M. (1995) · Cytopathology · doi:10.1111/j.1365-2303.1995.tb00469.x · Cited by 43
Ghosh, S. K., & Duigou, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0581 · Cited by 43
Gao-Liang, O. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i6.1053 · Cited by 40
Kozłowska, K., Nowak, J., Kwiatkowski, B., & Cichorek, M. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80074-8 · Cited by 40
Induction of Transient Ion Channel-Like Pores in a Cancer Cell by Antibiotic Peptide
Ye, J. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh114 · Cited by 30
DiPaola, C., & Mandel, I. D. (1980) · Journal of Dental Research · doi:10.1177/00220345800590090101 · Cited by 27
Surface configuration of human tumor cells obtained by fine needle aspiration biopsy.
Domagała, W., & Koss, L. G. (1980) · PubMed · Cited by 14
Cited by
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Self-citationKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Metadata
- Authors
- Mader, J. S., & Hoskin, D. W.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2006-07-21
- Volume
- 15
- Issue
- 8
- Pages
- 933-946
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2103567156
- Cited by
- 430
- References
- 100
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.